デフォルト表紙
市場調査レポート
商品コード
1363212

病理解剖の市場規模、シェア、動向分析レポート:製品・サービス別、最終用途別、地域別、セグメント別予測、2023年~2030年

Anatomic Pathology Market Size, Share & Trends Analysis Report, By Product & Services, By Application (Disease Diagnosis, Drug Discovery And Development), By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 176 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.87円
病理解剖の市場規模、シェア、動向分析レポート:製品・サービス別、最終用途別、地域別、セグメント別予測、2023年~2030年
出版日: 2023年09月25日
発行: Grand View Research
ページ情報: 英文 176 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

病理解剖市場の成長と動向:

Grand View Research, Inc.の新しいレポートによると、世界の病理解剖市場規模は2030年までに584億2,000万米ドルに達する見込みです。

2023年から2030年までのCAGRは8.7%で成長する見込みです。病理解剖的処置で使用される器具やプロトコルに技術が登場したことで、高度な病理解剖的器具の採用率が高まると予測されています。

市場プレーヤーは、革新的な疾患診断モデルを組み込んだ病理学製品の改修のために協力しています。2021年4月、ライカバイオシステムズはAIベースの診断会社であるペイジと提携し、トランスレーショナル研究や臨床研究のための計算病理学製品へのアクセスを拡大しました。この提携により、Paige社のAI対応研究ソフトウェアとライカバイオシステムズのデジタル病理学プラットフォームが統合されました。これにより、病理機器のアップグレードへの投資が加速されます。

公的機関や民間団体が病理医研修生に提供する病理学トレーニングプログラムが市場を牽引しています。例えば、Accreditation Council for Graduate Medical Education(卒後医学教育認定評議会)が認定する解剖学病理学の研修プログラムは、多くの教育会議を通じて個人に教育とトレーニングを提供しています。

従来の医療から個別化医療へのパラダイムシフトにより、予測期間中、創薬・医薬品開発アプリケーション分野が最も急成長すると予想されます。これは主に、個別化治療の開発においてバイオマーカーの発見への依存が高まっているためです。また、病理研修医が個別化医療の分野で起こっている進展を確実に認識できるようにするための病理研修プログラムの開発も、市場の成長を加速させています。

北米は、公的機関による多数の資金提供プログラムや主要企業の存在により、2020年に最大の売上シェアを占めました。アジア太平洋は、病理学トレーニングプログラムの実施に携わる複数の協会の存在により、最も速い成長が見込まれています。

主要企業は、市場での存在感を維持するために、M&Aや新製品開拓など、さまざまな戦略的取り組みを行っています。例えば、2021年5月、CellCartaはAIベースの病理学企業であるReveal Biosciencesを買収しました。この買収は、AIを活用したマルチオミクスデータ解析サービスとアプリケーションにおけるCellCartaの提供サービスの拡大を目的としています。

病理解剖市場レポートハイライト

  • 製品・サービス別では、消耗品分野が2022年に最大のシェアを占める。入手性の高さ、コストの低さ、消耗品の購入頻度の高さが同分野の成長に寄与しました。
  • 機器製品・サービス分野は予測期間中に最も速い成長が見込まれます。斬新なデザインの統合によりエラーのリスクを最小化する機器の技術的進歩が、このセグメントを牽引すると予想されます。
  • 疾患の診断に役立つあらゆる異常を特定する病理解剖的ツールの役割が増大しているため、疾患診断アプリケーション分野が2022年の市場を独占しました。診断プロセスにおける感染症や疾患の追跡・特定にバイオマーカーを使用することが、同分野の成長を押し上げると予想されます。
  • 最終用途別では、病院分野が2022年に最大シェアを獲得しました。これは、疾病モニタリングと診断のための病理ワークフローの採用を刺激する入院率の増加によるものです。
  • 診断検査室エンドユースセグメントの成長は、最先端の検査機器や計測器、複数の電子インターフェース、情報システムの使用によって促進されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 病理解剖市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 病理解剖市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 病理解剖:製品とサービスの推定・動向分析

  • 病理解剖市場:重要なポイント
  • 病理解剖市場:動向と市場シェア分析、2022年および2030年
  • 機器
    • ミクロトームとクライオスタット
    • 組織処理装置
    • 自動染色装置
    • ホールスライドイメージング(WSI)スキャナー
    • その他の製品
  • 消耗品
    • 試薬と抗体
    • プローブとキット
    • その他
  • サービス

第5章 病理解剖:用途推定・動向分析

  • 病理解剖市場:重要なポイント
  • 病理解剖市場:動向と市場シェア分析、2022年および2030年
  • 病気の診断
  • 創薬と開発
  • その他

第6章 病理解剖:最終用途推定・動向分析

  • 病理解剖市場:重要なポイント
  • 病理解剖市場:動向と市場シェア分析、2022年および2030年
  • 病院
  • 研究
  • 診断ラボ
  • その他

第7章 病理解剖市場:地域別の推定・動向分析

  • 地域別の見通し
  • 地域別の病理解剖市場:重要なポイント
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Danaher
    • PHC Holdings Corporation
    • Quest Diagnostics Incorporated
    • Laboratory Corporation of America Holdings
    • F. Hoffmann-La Roche AG
    • Agilent Technologies, Inc.
    • Cardinal Health
    • Sakura Finetek USA, Inc.
    • NeoGenomics Laboratories, Inc.
    • BioGenex
    • Bio SB
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 3 North America anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America anatomic pathology market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 7 U.S. anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 10 Canada anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 13 Europe anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe anatomic pathology market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 17 Germany anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 20 UK anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 23 France anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 24 France anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 26 Italy anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 29 Spain anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Sweden anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 32 Sweden anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Norway anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 35 Norway anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Denmark anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 38 Denmark anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific anatomic pathology market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 45 Japan anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan anatomic pathology market, by end use, (USD Million) 2018 - 2030
  • Table 47 China anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 48 China anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 49 China anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 51 India anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 52 India anatomic pathology market, by end use, (USD Million) 2018 - 2030
  • Table 53 Australia anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 54 Australia anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Thailand anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 57 Thailand anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 60 South Korea anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 63 Latin America anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America anatomic pathology market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 67 Brazil anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 70 Mexico anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 73 Argentina anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa anatomic pathology market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 80 South Africa anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 86 UAE anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE anatomic pathology market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait anatomic pathology market, by products & services, 2018 - 2030 (USD Million)
  • Table 89 Kuwait anatomic pathology market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait anatomic pathology market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Anatomic pathology: Market outlook
  • Fig. 9 Anatomic pathology: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Anatomic pathology market driver impact
  • Fig. 15 Anatomic pathology market restraint impact
  • Fig. 16 Anatomic pathology market strategic initiatives analysis
  • Fig. 17 Anatomic pathology market: Products & services movement analysis
  • Fig. 18 Anatomic pathology market: Products & services outlook and key takeaways
  • Fig. 19 Instruments estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Microtomes & cryostat estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Tissue processors estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Automatic stainers estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Whole slide imaging (WSI) scanners estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Other products estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Consumables estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Reagents & antibodies estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Probes & kits estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Services estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Services estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Anatomic pathology market: Application movement analysis
  • Fig. 32 Anatomic pathology market: Application outlook and key takeaways
  • Fig. 33 Disease diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Drug discovery and development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Anatomic pathology market: End use movement analysis
  • Fig. 37 Anatomic pathology market: End use outlook and key takeaways
  • Fig. 38 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Research laboratories delivery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Global anatomic pathology market: Regional movement analysis
  • Fig. 43 Global anatomic pathology market: Regional outlook and key takeaways
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-3-68038-318-8

Anatomic Pathology Market Growth & Trends:

The global anatomic pathology market size is expected to reach USD 58.42 billion by 2030, according to a new report by Grand View Research, Inc.. It is expected to grow at a CAGR of 8.7% from 2023 to 2030. The advent of technology in the instruments and the protocols used during the anatomic pathological procedures is anticipated to increase the adoption rate of advanced anatomic pathological instruments.

Market players are collaborating for the refurbishment of pathology products by the incorporation of innovative disease diagnostic models. In April 2021, Leica Biosystems collaborated with Paige, an AI-based diagnostics company, for expanded access to computational pathology products for translational and clinical research. Under this partnership, Paige's AI-enabled research software and Leica Biosystems' digital pathology platform were combined. This, in turn, accelerates investments in the up-gradation of pathological equipment.

Pathology-training programs offered to pathologist trainees by public and private entities drive the market. For instance, the Accreditation Council for Graduate Medical Education accredited residency programs for anatomic pathology provide education and training to individuals via numerous teaching conferences.

The drug discovery and development application segment are expected to witness the fastest growth over the forecast period due to the shifting paradigm from conventional medicine to personalized medicine. This is primarily due to the growing reliance on discoveries of putative biomarkers for the development of personalized therapies. Ongoing pathology training programs to ensure that the pathology residents are aware of the developments taking place in the field of personalized medicine have also accelerated the market growth.

North America held the largest revenue share in 2020 owing to a large number of funding programs by public agencies and the presence of key players. Asia Pacific is expected to witness the fastest growth due to the presence of multiple associations that are engaged in conducting pathology training programs.

Key players are undertaking various strategic initiatives such as mergers & acquisitions and new product development to maintain their market presence. For instance, in May 2021, CellCarta acquired Reveal Biosciences, an AI-based pathology firm. This acquisition is aimed at expanding CellCarta's offerings in AI-enabled multi-omic data analysis services and applications.

Anatomic Pathology Market Report Highlights:

  • By product and services, the consumables segment accounted for the largest share in 2022. High availability, low cost, and a frequent purchase rate of consumables contributed to the segment growth
  • The instruments product and services segment is expected to witness the fastest growth over the forecast period. Technological advancements in instruments to minimize the risk of errors through the integration of novel design are expected to drive the segment
  • The disease diagnosis application segment dominated the market in 2022 owing to the increasing role of anatomic pathological tools in identifying any anomalies that help diagnose a condition. The use of biomarkers for tracking and identifying infections and diseases during diagnostic processes is expected to boost the growth of the segment
  • In terms of end use, the hospitals segment captured the largest share in 2022 due to an increase in the hospitalization rate that stimulates the adoption of pathological workflows for disease monitoring and diagnosis
  • The diagnostic laboratories end-use segment growth is facilitated by the use of state-of-the-art laboratory equipment and instrumentation, multiple electronic interfaces, and information systems

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Products & services
    • 1.1.2. Application
    • 1.1.3. End use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Products & services outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Anatomic Pathology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Anatomic Pathology Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Anatomic Pathology: Products & Services Estimates & Trend Analysis

  • 4.1. Anatomic Pathology Market: Key Takeaways
  • 4.2. Anatomic Pathology Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Instruments
    • 4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Microtomes & cryostat
      • 4.3.2.1. Microtomes & cryostat market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Tissue processors
      • 4.3.3.1. Tissue processors market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Automatic stainers
      • 4.3.4.1. Automatic stainers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Whole slide imaging (WSI) scanners
      • 4.3.5.1. Whole slide imaging (WSI) scanners market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Other products
      • 4.3.6.1. Other products market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Reagents & antibodies
      • 4.4.2.1. Reagents & antibodies market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Probes & kits
      • 4.4.3.1. Probes & kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Anatomic Pathology: Application Estimates & Trend Analysis

  • 5.1. Anatomic Pathology Market: Key Takeaways
  • 5.2. Anatomic Pathology Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Disease Diagnosis
    • 5.3.1. Disease diagnosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Drug Discovery and Development
    • 5.4.1. Drug discovery and development market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Anatomic Pathology: End Use Estimates & Trend Analysis

  • 6.1. Anatomic Pathology Market: Key Takeaways
  • 6.2. Anatomic Pathology Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Research Laboratories
    • 6.4.1. Research laboratories delivery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Laboratories
    • 6.5.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Anatomic Pathology Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Anatomic Pathology Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. UK
      • 7.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. France
      • 7.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. China
      • 7.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. India
      • 7.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. South Africa
      • 7.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Danaher
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. PHC Holdings Corporation
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Quest Diagnostics Incorporated
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Laboratory Corporation of America Holdings
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. F. Hoffmann-La Roche AG
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Agilent Technologies, Inc.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Cardinal Health
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Sakura Finetek USA, Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. NeoGenomics Laboratories, Inc.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. BioGenex
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Bio SB
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives